MAM
Ranjeet Kamtekar named president & sales head at Xanadu Bengaluru
Mumbai: Xanadu Realty has announced the appointment of Ranjeet Kamtekar as president and head of sales for its Bengaluru operations. He will be responsible for establishing Xanadu Realty’s formidable presence as a ‘business accelerator’ in the South market and play a pivotal role in delivering on Xanadu’s promise to its clients, said the company.
“Xanadu has ventured into the real estate sector in Bengaluru in the second half of 2020, and we’re certain that Ranjeet’s extensive experience in sales will add immense value to our business operations there,” said Xanadu Realty, CEO, Vikas Chaturvedi. “We are sure that his stellar track record and professional abilities will be a driving force behind establishing Xanadu’s presence in the center of India’s IT hub.”
Kamtekar comes with over 17 years of experience in the sales and business development domains and has extensively worked in BFSI and real estate industries. He has been associated with Xanadu Realty Mumbai, for about five years now, during which he has helmed several residential and commercial projects. He has also played an integral role in the establishment of various business verticals – corporate sales, outstation sales, and channel partner network distribution, providing a significant boost to the overall growth of Xanadu Realty in Mumbai.
In his impressive career graph, Kamtekar has worked as a sales manager-lending for ICICI Bank Ltd and as an AVP and senior relationship manager, business banking for HSBC. In the real estate sector, he was associated with the Lodha Group as the GM, where he was responsible for identifying various opportunities to drive deeper market penetration.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
